Henry Y M, Eastell R
Bone Metabolism Group, Section of Medicine (NGHT), Division of Clinical Sciences, University of Sheffield, UK.
Osteoporos Int. 2000;11(6):512-7. doi: 10.1007/s001980070094.
Generally, the incidence of osteoporotic fracture is lower in black populations and in men. These effects of ethnicity and gender may result from differences in peak bone mineral density (PBMD) and bone turnover (BT), which in turn are affected by bone size. Therefore, the aims of this study were to examine the effects of ethnicity and gender on bone mineral density (BMD) and BT in young African-Caribbean and Caucasian adults, and to adjust for the effect of bone size on BMD and BT. BMD was measured at the lumbar spine, L2-L4 (LS), total body (TB) and femoral neck (FN) by dual-energy X-ray absorptiometry in 44 blacks (16 men, 28 women) and 59 whites (28 men, 31 women) ages 20-37 years. We measured serum bone-specific alkaline phosphatase (BAP) and serum osteocalcin (OC) as markers of bone formation and urinary immunoreactive free deoxypyridinoline (ifDpd) and crosslinked N-telopeptide of type I collagen (NTx) as markers of bone resorption. To adjust the data for any differences in bone size, we calculated: (a) bone mineral apparent density (BMAD), an estimated volumetric bone density which attempts to normalize BMD measurements for bone size; and (b) bone resorption markers as a ratio to total body bone mineral content (TB BMC). Two-way analysis of variance was used to compare the effects of race and gender, and to test for any interaction between these two factors. Blacks had higher BMD compared with whites at the TB (p<0.001), LS (p = 0.0001) and FN (p = 0.0005). This increase remained significant at the LS only after calculating BMAD. Men had higher BMD at all sites (except at the LS). This increase was no longer significant at the FN after calculating BMAD, and LS BMAD was actually greater in women (p<0.0001). Blacks and whites had similar concentrations of turnover markers, but men had higher bone turnover markers than women (BAP, p<0.0001; OC, p = 0.002; ifDpd, p = 0.03; NTx, p < 0.0001). This increase in bone resorption markers was no longer significant after adjusting for TB BMC (except for NTx in whites). We conclude that the skeletal advantage in blacks during young adulthood is not explained by bone size. However, it seems probable that bone size effects partially explain gender differences in BMD and bone turnover.
一般来说,骨质疏松性骨折的发生率在黑人人群和男性中较低。种族和性别的这些影响可能源于峰值骨密度(PBMD)和骨转换(BT)的差异,而这又受骨骼大小的影响。因此,本研究的目的是检验种族和性别对年轻非洲 - 加勒比和白种成年人骨密度(BMD)和BT的影响,并校正骨骼大小对BMD和BT的影响。通过双能X线吸收法在44名黑人(16名男性,28名女性)和59名20 - 37岁的白人(28名男性,31名女性)中测量腰椎L2 - L4(LS)、全身(TB)和股骨颈(FN)的骨密度。我们测量血清骨特异性碱性磷酸酶(BAP)和血清骨钙素(OC)作为骨形成标志物,以及尿免疫反应性游离脱氧吡啶啉(ifDpd)和I型胶原交联N - 端肽(NTx)作为骨吸收标志物。为校正骨骼大小的任何差异的数据,我们计算了:(a)骨矿物质表观密度(BMAD),一种估计的体积骨密度,试图使BMD测量值因骨骼大小而标准化;(b)骨吸收标志物与全身骨矿物质含量(TB BMC)的比值。采用双向方差分析比较种族和性别的影响,并检验这两个因素之间的任何相互作用。黑人在TB(p<0.001)、LS(p = 0.0001)和FN(p = 0.0005)处的BMD高于白人。仅在计算BMAD后,LS处的这种增加仍具有显著性。男性在所有部位(除LS外)的BMD较高。在计算BMAD后,FN处的这种增加不再显著,并且女性的LS BMAD实际上更高(p<0.0001)。黑人和白人的骨转换标志物浓度相似,但男性的骨转换标志物高于女性(BAP,p<0.0001;OC,p = 0.002;ifDpd,p = 0.03;NTx,p < 0.0001)。在调整TB BMC后,骨吸收标志物的这种增加不再显著(白人中的NTx除外)。我们得出结论,黑人在成年早期的骨骼优势不能用骨骼大小来解释。然而,骨骼大小效应似乎部分解释了BMD和骨转换中的性别差异。